Figure 2.

Cardiovascular risk in patients with arthritis: celecoxib versus NSAIDs, naproxen, or placebo. Shown is a summary of the risk for death, myocardial infarction, and stroke for celecoxib relative to nonsteroidal anti-inflammatory drugs (NSAIDs), naproxen, or placebo in patients with arthritis [30]. *P = nonsignificant. Reproduced with permission from Elsevier [30].

Borer and Simon Arthritis Research & Therapy 2005 7(Suppl 4):S14-S22   doi:10.1186/ar1794